Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Genmab ( (GMAB) ) is now available.
Genmab A/S filed a Form 6-K with the U.S. Securities and Exchange Commission dated April 17, 2026, publishing an updated English translation of its Articles of Association as of March 19, 2026. The filing formalizes existing authorizations for the board to issue new shares, employee warrants and convertible debt, clarifies the company’s group language as English, and maintains Copenhagen as its registered office.
The revised Articles keep the share capital at DKK 62,350,721 while allowing the board, until March 2029 or 2030 depending on the program, to raise additional equity without or with pre-emption rights, grant employee warrants and issue convertible instruments up to specified nominal limits. These measures give Genmab added flexibility in capital raising and employee incentive structures, potentially supporting future financing and expansion without needing frequent shareholder meetings.
The most recent analyst rating on (GMAB) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Genmab stock, see the GMAB Stock Forecast page.
Spark’s Take on GMAB Stock
According to Spark, TipRanks’ AI Analyst, GMAB is a Neutral.
The score is supported by strong financial performance (rapid growth, high margins, solid cash generation) and a constructive earnings outlook with meaningful pipeline catalysts, but is held back by the sharp 2025 leverage increase and weaker earnings quality signals, plus bearish near-term technical momentum despite oversold readings.
To see Spark’s full report on GMAB stock, click here.
More about Genmab
Genmab A/S is a Denmark-based biotechnology company focused on medical research, development, production and sale of pharmaceutical products. The company operates through a share capital structure denominated in Danish kroner and uses equity, warrants and convertible instruments to finance growth and incentivize employees.
Average Trading Volume: 1,641,098
Technical Sentiment Signal: Hold
Current Market Cap: $17.9B
For an in-depth examination of GMAB stock, go to TipRanks’ Overview page.